Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation Asset disposition
|
Translate Bio, Inc. (TBIO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/16/2021 |
4/A
| BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Disposed of 18,044,239 shares
@ $38, valued at
$685.7M
|
|
09/14/2021 |
4
| Sutherland Everett Rand (President) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 300,000 options to buy
@ $16.37, valued at
$4.9M
|
|
09/14/2021 |
4
| Smith Brendan (CFO) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 201,800 options to buy
@ $19.23, valued at
$3.9M
|
|
09/14/2021 |
4
| Renaud Ronald C JR (CEO) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 503,231 shares
@ $38, valued at
$19.1M
Sold 409,913 shares
@ $38, valued at
$15.6M
Sold 40,909 shares
@ $38, valued at
$1.6M
Sold 500,000 options to buy
@ $7.95, valued at
$4M
Sold 525,000 options to buy
@ $7.66, valued at
$4M
Sold 325,000 options to buy
@ $23.82, valued at
$7.7M
Sold 1,071,009 options to buy
@ $7.39, valued at
$7.9M
Sold 89,996 options to buy
@ $8.34, valued at
$750.6k
|
|
09/14/2021 |
4/A
| Renaud Ronald C JR (CEO) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Exercised 9,026 options to buy
@ $7.39, valued at
$66.7k
|
|
09/14/2021 |
4
| Burgess Paul D. (COO, CLO) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 71,833 shares
@ $38, valued at
$2.7M
Sold 219,652 options to buy
@ $7.39, valued at
$1.6M
Sold 69,953 options to buy
@ $8.34, valued at
$583.4k
Sold 150,000 options to buy
@ $7.95, valued at
$1.2M
Sold 150,000 options to buy
@ $7.66, valued at
$1.1M
Sold 90,000 options to buy
@ $23.82, valued at
$2.1M
|
|
09/14/2021 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 37,800 options to buy
@ $12.36, valued at
$467.2k
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
09/14/2021 |
4
| Meyer Robert J. (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 37,800 options to buy
@ $7.49, valued at
$283.1k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
09/14/2021 |
4
| Hughes Owen (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 29,860 shares
@ $38, valued at
$1.1M
Sold 38,135 options to buy
@ $7.39, valued at
$281.8k
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
09/14/2021 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 37,800 options to buy
@ $10.15, valued at
$383.7k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
09/14/2021 |
4
| FORMELA JEAN FRANCOIS (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 2,055,063 shares
@ $38, valued at
$78.1M
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
Sold 37,800 options to buy
@ $8.34, valued at
$315.3k
|
|
09/14/2021 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 37,800 options to buy
@ $10.15, valued at
$383.7k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
09/14/2021 |
4
| Beckman Daniella (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 67,995 options to buy
@ $7.39, valued at
$502.5k
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
09/14/2021 |
4
| Sanofi (10% Owner) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Bought 51,467,612 shares
@ $38, valued at
$1955.8M
Bought 20,515,985 shares
@ $38, valued at
$779.6M
|
|
08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
06/16/2021 |
4
| Meyer Robert J. (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2021 |
4
| Smith Brendan (CFO) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 201,800 options to buy
@ $19.23, valued at
$3.9M
|
|
04/20/2021 |
3
| Smith Brendan (CFO) has filed a Form 3 on Translate Bio, Inc. |
04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2021 |
4
| Sutherland Everett Rand (President) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 300,000 options to buy
@ $16.37, valued at
$4.9M
|
|
03/23/2021 |
3
| Sutherland Everett Rand (President) has filed a Form 3 on Translate Bio, Inc. |
03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/23/2020 |
4
| FORMELA JEAN FRANCOIS (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Sold 56,536 shares
@ $25.5046, valued at
$1.4M
Sold 79,865 shares
@ $25.0421, valued at
$2M
Sold 2,700 shares
@ $25.8825, valued at
$69.9k
|
|
11/18/2020 |
4
| Renaud Ronald C JR (CEO, Pres.) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Exercised 53,004 options to buy
@ $7.39, valued at
$391.7k
Exercised 3 options to buy
@ $8.34, valued at
$25 |
|
08/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|